少林足球

Explained: Here’s Why Court Halted The Release of Balakrishna’s Film Akhanda 2_我的网站

一 |     8月26日消息，中国首富钟睒睒再开启大额公益捐赠，此次捐赠资产价值高达9.27亿元。    Dark clouds loomed over the release of Balakrishna’s film Akhanda 2 after Madras High Court stalled the film’s release on Wednesday. While the producers of the action entertainer tried their best to bail out the film, their efforts went in vain. As a result, Akhanda 2, which was slated to release on Friday (December 5, 2025), isn’t releasing as scheduled. The production house, 14 Reels Plus, officially confirmed the news on their social media handle. The unfortunate development certainly came in as a big disappointment for the fans who have been waiting with bated breath to see their favourite star (Balakrishna) in action.          With a heavy heart, we regret to inform you that #Akhanda2 will not be releasing as scheduled due to unavoidable circumstances.This is a painful moment for us, and we truly understand the disappointment it brings to every fan and movie lover awaiting the film.We are working…     — 14 Reels Plus (@14ReelsPlus) December 4, 2025               Akhanda 2 release postponed indefinitely     At a time when the buzz about Akhanda 2 reached fever pitch, the release of the Balakrishna-starrer was halted. A statement from the filmmakers read, “With a heavy heart, we regret to inform you that Akhanda 2 will not be released as scheduled due to unavoidable circumstances. This is a painful moment for us, and we truly understand the disappointment it brings to every fan and movie lover awaiting the film.” While tendering apologies and the inconvenience caused in this regard, the filmmakers assured fans that they are working towards resolving the matter and promised to share a positive update soon.     Legal dispute     In 2019, an arbitral tribunal directed 14 Reels Entertainment to pay Eros International Rs 11.23 crore over a financial and rights-related agreement emerged from the film Dookudu. In 2020, The Madras High Court had also dismissed 14 Reels Entertainment’s petition challenging the earlier award. A Division Bench, and subsequently the Supreme Court too dismissed 14 Reels Entertainment’s SLP in 2021. Meanwhile, Eros International too did not appeal against 14 Reels Entertainment for ‘contempt of court’ for four years.In August 2025, Eros learnt that the debtor company (14 Reels Entertainment) is making and releasing a film Akhanda 2 with a new legal entity named 14 Reels Plus LLP. The Applicant moved Madras High Court arguing that the LLP was controlled by family/associates of the same promoters of 14 Reels Entertainment. Eros further alleged that the promoters were attempting to bypass an unpaid arbitral sum and described it as an alter ego. The Court also heard the arguments of the Respondents 14 Reels Entertainment and 14 Reels Plus LLP. After hearing all the arguments, setting a single Judge’s order (of setting Akhanda 2 free from all legal constraints in October 2025) aside, The Division Bench of the Court freshly ordered that Akhanda 2 cannot be released, distributed, streamed unless 14 Reels Entertainment / 14 Reels Plus LLP pays the entire arbitral payment with interest.          Akhanda 2 premieres cancelled     The premieres of Akhanda 2 were scheduled on December 4 at various screens in the Telugu speaking states and also abroad (North America and Europe). But they had to be cancelled at the last minute due to court restraint. Also, the online bookings of the film on various ticketing portals have been kept on hold. Fans have been expressing their disappointment and are hoping that the film will see the light at the earliest.     Also Read: Madras High Court Puts Balakrishna’s Akhanda 2 Release on Hold。

二 |     8月25日盘后，北京万泰生物药业股份有限公司发布官方公告。公告显示，公司实际控制人钟睒睒，将其直接持有的3300万股万泰生物无限售流通股，无偿捐赠给福建省翔安创新实验室科技发展基金会，本次捐赠股份占公司总股本的2.61%。     本次捐赠完成后，钟睒睒个人直接持股比例从17.71%降至15.10%；其与控股股东养生堂的合计持股比例，由73.53%降至70.92%。    据悉，本次受赠方福建省翔安创新实验室科技发展基金会为慈善组织，于2025年11月27日正式成立。    根据公告约定，受赠方持有本次捐赠股份期间，所产生的全部收益（包含股息、红利及各类法定孳息等），以及后续减持该部分股份所得的税后资金，将专项用于公共健康与生物医学前沿领域的科研探索、人才培养、科技奖励及学术交流等公益事业。    公告同时明确，此次捐赠不会改变万泰生物的控股股东及实际控制人，对公司现有治理结构、日常经营及持续发展均不会产生重大影响。

三 |     此外，受赠方承诺，6个月内不会减持本次获赠股份，且未来进行股份减持时，将与钟睒睒合并计算减持额度，合规规范运作。     

    公开资料显示，万泰生物成立于1991年，2020年4月在上交所成功上市，养生堂为其控股股东，钟睒睒作为农夫山泉创始人，是公司最终实际控制人，且曾多次登顶中国首富榜单。

四 |     值得一提的是，这也是钟睒睒近10个月内的第二次大额公开捐赠，两次捐赠合计价值达10.27亿元。     此前在2025年11月22日，诸暨市教育大会上，诸暨市教育强市奖励基金正式成立，现场累计收到各类企业1.42亿元捐赠。其中，钟睒睒以个人名义向诸暨中学捐赠1亿元，设立诸暨中学钟子逸教育基金项目。

五 |     据了解，钟睒睒祖籍诸暨，钟子逸是其祖父，钟子逸教育基金是由钟睒睒创立，由其名下的非上市公司出资，将专款用于诸暨中学的助学与奖教奖学。     长期以来，钟睒睒深耕教育公益领域。其依托“钟子逸教育基金”，持续捐助清华大学、北京大学、浙江大学、西湖大学、厦门大学等多所国内知名高校，累计捐赠金额达数亿元。    且其过往多数捐赠均为匿名开展，不举办仪式、不对外宣传，直到2024年才被媒体发掘披露。     财富榜单数据显示，在2025胡润百富榜中，钟睒睒财富较此前增长1900亿元，以5300亿元的财富总值第四次登顶中国首富，刷新了中国首富财富纪录。    他也成为继马云之后，第二位四次登顶中国首富的企业家，二人同为绍兴籍企业家。    而在2026年3月发布的福布斯全球亿万富豪榜中，钟睒睒以681亿美元财富位居国内榜单第二位。

六 |     

七 |

Current article:http://r1hzlaj.yofateeikengyeche.cfd/kke/20260826/1200.html

Published on:13:05:54